Sidell Neil, Feng Yue, Hao Lijuan, Wu Juanjuan, Yu Jie, Kane Maureen A, Napoli Joseph L, Taylor Robert N
Division of Research, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia 30322, USA.
Mol Endocrinol. 2010 Jan;24(1):148-60. doi: 10.1210/me.2009-0155. Epub 2009 Nov 12.
Vascular endothelial growth factor (VEGF) and endometrial angiogenesis play a critical role in successful embryonic implantation. Despite many studies of the effects of estrogen and progesterone on VEGF expression, its focal regulation at the site of implantation is unknown. Retinoic acid (RA) has been reported to regulate VEGF in a variety of cell types. Because localized RA synthesis occurs within the periimplantation endometrium, we tested the possibility that RA regulates VEGF production in endometrial stromal cells. Using primary and telomerase-immortalized human endometrial stromal cells, we determined that RA alone did not alter constitutive levels of VEGF production, but markedly amplified secretion when the cells were cotreated with activators of VEGF gene transcription (12-O-tetradecanoyl phorbol-13-acetate, TPA; TGF-beta; and IL-1beta). Whereas TPA or TGF-beta alone stimulated VEGF promoter activity and up-regulated mRNA levels, significant protein secretion was detected only after RA was added to the culture systems. Analysis of retinoids in secretory phase endometrial biopsies indicated that endogenous RA accumulated at concentrations sufficient to induce VEGF secretion. Polyribosome profile analysis showed that the addition of RA to transcriptional activators of VEGF shifted the translational suppressed VEGF mRNA transcripts into larger polyribosome complexes engaged in active translation. Although the precise mechanism(s) of the RA effect remains to be defined, it appears to be mediated by reactive oxygen species; the antioxidant N-acetylcysteine inhibited RA+TPA-stimulated secretion of VEGF by more than 80%. Together, our results demonstrate that in human endometrial stromal cells, RA can combine with transcriptional activators of VEGF to augment VEGF secretion through a translational mechanism of action mediated by reactive oxygen species. These findings suggest a link between the spatiotemporal changes of retinoid synthesis in the periimplantation stroma and the capacity to quickly up-regulate focal VEGF secretion needed to induce early angiogenic events of pregnancy.
血管内皮生长因子(VEGF)和子宫内膜血管生成在胚胎成功着床中起关键作用。尽管有许多关于雌激素和孕激素对VEGF表达影响的研究,但其在着床部位的局部调节尚不清楚。据报道,视黄酸(RA)可调节多种细胞类型中的VEGF。由于着床期子宫内膜内会发生局部RA合成,我们测试了RA调节子宫内膜基质细胞中VEGF产生的可能性。使用原代和端粒酶永生化的人子宫内膜基质细胞,我们确定单独的RA不会改变VEGF产生的组成水平,但当细胞与VEGF基因转录激活剂(12 - O - 十四烷酰佛波醇 - 13 - 乙酸酯,TPA;TGF - β;和IL - 1β)共同处理时,会显著增强分泌。单独的TPA或TGF - β刺激VEGF启动子活性并上调mRNA水平,但仅在向培养系统中添加RA后才检测到显著的蛋白质分泌。分泌期子宫内膜活检中类视黄醇的分析表明,内源性RA以足以诱导VEGF分泌的浓度积累。多核糖体谱分析表明,将RA添加到VEGF的转录激活剂中会将翻译受抑制的VEGF mRNA转录本转移到参与活跃翻译的更大的多核糖体复合物中。尽管RA作用的确切机制仍有待确定,但它似乎是由活性氧介导的;抗氧化剂N - 乙酰半胱氨酸抑制RA + TPA刺激的VEGF分泌超过80%。总之,我们的结果表明,在人子宫内膜基质细胞中,RA可与VEGF的转录激活剂结合,通过活性氧介导的翻译作用机制增强VEGF分泌。这些发现提示了着床期基质中类视黄醇合成的时空变化与诱导妊娠早期血管生成事件所需的快速上调局部VEGF分泌能力之间的联系。